BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6071187)

  • 1. Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
    Werner SC; Feind CR; Aida M
    N Engl J Med; 1967 Jan; 276(3):132-8. PubMed ID: 6071187
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the active severe eye changes of Graves' disease.
    Werner SC
    Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of hyperthyroidism induced by thyroid extracts].
    Laroche C; Remy JM
    Rev Fr Endocrinol Clin; 1970; 11(4):295-302. PubMed ID: 5537800
    [No Abstract]   [Full Text] [Related]  

  • 4. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
    Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
    Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxic adenoma of the thyroid (study of 120 cases)].
    Papalia D; Vigneri R; Motta L
    Folia Endocrinol; 1968 Aug; 21(4):501-28. PubMed ID: 5757117
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent thyrotoxicosis after subtotal thyroidectomy.
    Hedley AJ; Ross IP; Beck JS; Donald D; Albert-Recht F; Michie W; Crooks J
    Br Med J; 1971 Oct; 4(5782):258-61. PubMed ID: 5171384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperthyroidism and thyroid cancer].
    Guinet P; Tourniaire J; Radi A; Briere J; Bryon PA; Dutrieux N; Guillaud M; Maillet P; Sassolas G; Soustelle J
    Rev Fr Endocrinol Clin; 1972; 13(3):199-227. PubMed ID: 4679022
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term follow-up after thyroidectomy].
    Scazziga BR
    Helv Chir Acta; 1978 Jan; 44(5-6):741-5. PubMed ID: 580089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-acting thyroid stimulator and thyroid disease.
    Kriss JP
    Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
    Prendergast JJ; Miller JM
    Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
    [No Abstract]   [Full Text] [Related]  

  • 15. Managment of functioning thyroid cancer.
    Hales I; Reeve T; Johnson D
    Med J Aust; 1969 Feb; 1(8):372-8. PubMed ID: 4181184
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
    Nutt J; Clark F; Welch RG; Hall R
    Br Med J; 1974 Dec; 4(5946):695-6. PubMed ID: 4479947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxic adenoma. Study of 35 cases].
    Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
    Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
    [No Abstract]   [Full Text] [Related]  

  • 18. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basdowian ophthalmic diseases. Pathogenic role of L-triiodothyronine and of LATS. Therapeutic role of L-thyroxine, of d-thyroxine and of corticoids].
    Mahaux JE; Nagel M
    Brux Med; 1967 Oct; 47(43):1003-16. PubMed ID: 4193087
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperthyroidism.
    Kendall-Taylor P
    Br Med J; 1972 May; 2(5809):337-41. PubMed ID: 4112238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.